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1. Introduction 
The transvenous insertion of implantable pacemaker (PM) and implantable cardioverter 
defibrillator (ICD) leads was a major milestone in antiarrhythmic therapy with the use of 
cardiac devices. Indeed, based on data published over the last decade the indications for 
ICD therapy have further expanded [1,2] while cardiac resynchronization therapy (CRT) 
through bi-ventricular pacing has significantly improved mortality and quality of life in 
patients with heart failure and ventricular dyssynchrony [3,4,5]. Unfortunately, this 
exponential increase in the implantation rate of cardiac devices has been accompanied by a 
parallel increase in the need for explanting some of those [6]. This has been mainly 
attributed to the so called “increased total lead exposure time” resulting from the expanding 
indications for device treatments, the implantation of more leads per patient and the longer 
average life expectancy of device-recipients [7]. Lead removal has been performed only in 
limited centers from physicians with some expertise in this subject. The volume of 
procedures in these centers has also been increasing in a continuous manner and the 
techniques applied have become more and more sophisticated and effective. Indeed, the 
options for lead extraction were initially very limited and dedicated tools were not available. 
Life threatening situations such as infection with sepsis were the only reason to attempt a 
lead removal with these highly morbid and often ineffective techniques [8]. As a necessity to 
overcome these limitations a significant evolution in lead extraction technology occurred 
over the past 30 years. More simple, safe and efficacious techniques are nowadays widely 
used in clinical practice [9].  
Dealing with a possible lead extraction, the main technical problems that have to be taken 
into consideration are: the endovascular reaction surrounding the intravenous lead, the 
physical characteristics of the lead affecting its removability and the lack of direct 
visualization along the intravascular route. Fibrotic scar tissue develops at areas of 
endothelial contact and engulfs the leads. This process begins with thrombus development 
along the lead at the time of implantation. Fibrosis of the thrombus occurs next resulting in 
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almost complete encapsulation of the lead with a fibrin sheath within 4-5 days post implant 
[10,11]. Calcification of the fibrous tissue may even occur over time especially in young 
patients [12]. The most common adhesion sites include the venous entry site, the superior 
vena cava and the electrode-endocardial interface [13]. (Figure 1). In the majority of patients 
multiple areas of scar tissue are found. This scar resists against lead explantation and 
specific manipulations are needed to overcome this particular obstacle. In addition, lead to 
lead interaction and binding in the case of multiple leads as well as along each of the 
shocking coils of the ICD leads may happen, which may pose further limitations in the 
extraction procedure (Figure 2).  
 
Figure 1. Location of areas of lead adherence. 
On the other hand, the material and construction of the lead may promote or resist the 
development of scar tissue and may also largely affect the lead removability through its 
specific tensile strength characteristics. To combat the formation of fibrous connections, 
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manufacturers have recently attempted to produce ICD coils coated with expanded 
polytetrafluoroethylene (ePTFE) or back-filled with medical adhesive (MABF). Both have 
been shown to be easier to extract due to decreased incidence of fibrosis on and around the 
filters of the coils [14]. Finally, the indirect control on the procedure from the operator due to 
the lack of direct visualization urges the outmost care and experience in order to avoid any 
major or even life-threatening consequences. Because lead extraction is not frequently 
performed, few high-volume centers can provide the best patient care along with 
opportunities for adequate physician training in this field. Both European and American 
Societies of Electrophysiology have set standards for training and accreditation in order to 
overcome these limitations. Generally, a minimum of 40 lead extractions as the primary 
operator is required to be considered fully trained, and 20 leads per year is needed to 
maintain competency [6,15].  
 
Figure 2. Extensive scarring over an extracted ICD lead. 
2. Indications for lead extraction 
Indications for device removal can be divided in two categories: infectious and non-infectious. 
Non-infectious indications include malfunctioning leads or leads which through their 
presence can cause harm to the patient (for example thrombosis of the superior vena), as 
well as leads that have to be removed in order to upgrade a device. In all published reports, 
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infection seems to be the most common indication for lead extraction (54-60% of all 
extraction procedures)[16,17]. 
Previous reports have indicated an overall rise in the rate of device infection which might 
have been attributed to the wider implantation of ICDs for primary prevention of sudden 
cardiac death in a population whose health status is by definition relatively poor (patients 
post myocardial infarction with low ejection fraction and clinical signs of heart failure). 
Another reason could have been the subsequent generator changes whose rate has been 
following the increasing rate of initial implantation. Both ICD implantation and generator 
replacement have been clearly associated with a higher rate of device infections [18,19]. 
On the other hand, others have more recently reported that referrals for extraction for 
infection and upgrade of the device have remained relatively stable in contrast to the 
incidence of lead failure which seems to have decreased over the last decade (Figure 3) 
[20].  
 
 
 
 
 
 
Figure 3. Indications for lead extraction in a cohort of 498 patients. There is a clear trend in the 
decreasing indication for lead removal due to malfunction. Referrals for extraction for infection and 
upgrade of the device have remained relatively stable over time (From: Jones SO, et al. Large, single-center, 
single-operator experience with transvenous lead extraction: Outcomes and changing indications. Heart Rhythm 
2008:5;520-525, with permission) 
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The indication to remove a lead in all the above circumstances is largely dependent on 
patient’s age, general condition, the potential of future problems, the risk to extract and 
the potential harmful circumstances associated with the lead presence such as subclavian 
or superior vena cava thrombosis. However, infection of the device regardless of its 
presentation makes the removal of the whole system unavoidable. This has been shown to 
be the only effective way to totally resolve this potentially life-threatening health problem. 
Staphylococcal infections dominate the responsible flora. In a recent survey Methicillin-
sensitive S. aureus was found in 25% Methicillin-resistant S. aureus was found in 34% and 
Coagulase-negative S. species were found in 14% of the cases of pacemaker endocarditis 
[21]. It should be noted that even if the infection is by clinical examination found to be 
confined to the pocket of the device, complete removal of the system including the leads 
has to be performed in order to avoid future relapse of the disease in the form of 
endocarditis. Studies have shown that leads not thought to be infected may in fact be 
heavily colonized by bacteria entering the systemic circulation at the pocket site [22,23]. 
Indeed, the majority of extraction procedures are currently performed for infections 
localized to the device pocket. Nevertheless, a more widespread infection is not 
uncommon. In a recent review of 189 patient admitted in a single tertiary center with 
device infection, pocket infection was present in 52% of them while 17% had evidence of 
pocket infection with blood stream infection and 23% had developed device-related 
endocarditis [24] Finally, even in patients presenting with an erosion of the pocket, as a 
consequence of infection or mechanical pressure or both, the system should be considered 
contaminated and has to be completely removed. Of note, adherence of the generator or 
leads to the skin often proceeds erosion and is an indication for extraction too (Figure 4) 
[6,15]. Nevertheless, a few authors may still advocate a conservative approach with 
debridement and chronic antibiotic administration in elderly, infirmary patients with a 
limited life expectancy [25].  
Controversy continues to exist regarding the other indications for lead removal. The risk 
posed by abandoned leads is relatively low. Thus many physicians would recommend 
simply abandoning malfunctioning leads. The opposite is however true as well. In most of 
the series the attempts to remove abandoned leads has been associated with a relatively low 
risk of complications. Accordingly, in the hands of more experienced operators non-
functioning leads may become a challenge for an extraction attempt [26]. Moreover, the risk 
of venous obstruction seems to increase proportionally to the number of leads and this has 
raised some additional concerns regarding the safety of leaving “orphan” leads in place. 
Accordingly, the decision of explanting a non-infected lead needs to be individualized in 
most of the cases. The cause of malfunction is insulation defect in the majority of pacemaker 
lead failures [27]. In the case of ICDs, high-voltage coil failures and disruption of the 
polyurethane inner insulators represent the most common reason that may lead to a lead 
replacement. Of note, ICD lead failure rate is not at all negligible. In a recent survey failure 
rate reached 20% in 10-year-old leads [28].  
A comprehensive list of lead removal indications has been recently published in Heart 
Rhythm Society expert Consensus Statement (Table 1). Nevertheless, it is important to 
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remember that selection of the patients for lead extraction should be done on an 
individual case-by-case basis taking always into account the patient’s clinical picture and 
general health status, the lead characteristics and the operator’s experience along with 
the availability of the specific facilities and tools. Only in the case that the risk of 
extraction is lower in comparison to the risk of lead abandonment a procedure should be 
attempted. 
 
 
Figure 4. Device adherence to the overlying skin with initiation of erosion 
3. The extraction procedure 
The goal of extraction techniques of chronic pacemaker and defibrillator leads is to present 
an approach that is successful in extracting all leads and minimizes or eliminates 
complications. Separating the lead from the encapsulating inflammatory tissue is the most 
crucial step in this process. However, regardless of the technique that will be used, clinicians 
must be prepared to deal with the fact that this procedure may vary from a simple to an 
extremely complicated one. Thus, careful planning of the procedure along with meticulous 
patient preparation seems mandatory.  
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Indication Class I 
Procedure should be 
performed 
Class IIa Reasonable 
to perform 
procedure  
Class IIb 
Procedure may be 
considered 
Class III Procedure 
should not be 
performed 
Infection 1. Definite infection of 
CIED e.g.device 
endocarditis or sepsis 
(LOE: B) 
2. CIED pocket 
infection e.g. abscess, 
erosion or chronic 
draining sinus 
 (LOE: B) 
3. Valvular 
endocarditis w/o 
definite lead and/or 
device involvement 
(LOE: B) 
4. Occult gram-
positive bacteraemia 
(LOE: B) 
 
Persistent occult 
gram-negative 
bacteraemia (LOE:B) 
 1. Superficial or 
incisional infection 
w/o involvement 
of device/leads 
(LOE: C) 
2. Chronic 
bacteraemia due to 
a source other than 
CIED when long 
term suppressive 
antibiotics are 
required (LOE: C) 
Thrombosis or 
venous stenosis 
1. Clinically 
significant TE events 
associated 
with thrombus on 
lead or fragment 
(LOE: C) 
2. Bilateral SCV or 
SVC occlusion 
precluding 
implant of needed TV 
lead (LOE: C) 
3. Planned stent 
deployment in vein 
with TV lead already 
to avoid entrapment 
(LOE: C) 
4. Symptomatic SVC 
stenosis/occlusion 
(LOE: C) 
5. Ipsilateral venous 
occlusion precluding 
implant of additional 
lead when 
contralateral implant 
contraindicated (AVF, 
shunt or vascular 
access port, 
mastectomy)  
(LOE: C) 
 
Ipsilateral venous 
occlusion precluding
ipsilateral implant of 
additional lead w/o 
contraindication to 
contralateral implant
(LOE: C) 
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Indication Class I 
Procedure should be 
performed 
Class IIa Reasonable 
to perform 
procedure  
Class IIb 
Procedure may be 
considered 
Class III Procedure 
should not be 
performed 
Functional leads 1. Life threatening 
arrhythmias due to 
retained leads 
 (LOE: B) 
2. Leads, due to 
design or failure, may 
pose immediate threat 
if left in place 
 (LOE: B) 
3. Leads that interfere 
with CIED function 
(LOE: B) 
4. Leads that interfere 
with treatment of 
malignancy 
(radiation, surgery) 
(LOE: C) 
 1. Leads w/potential 
interference with 
CIED function 
 (LOE: C) 
2. Leads, due to 
design or failure, 
with potential threat 
if left in place (LOE: 
C) 
3. Abandoned leads 
(LOE: C) 
4. Need for MRI 
imaging w/o 
alternative (LOE: C) 
5. Need for MRI 
conditional CIED 
system (LOE: C) 
1. Redundant leads 
with <1 year life 
expectancy 
(LOE: C) 
2. Known 
anomalous lead 
placement (SCA, 
Ao, pleura, etc) or 
through a systemic 
atrium or 
ventricle* (LOE: C) 
3. *Can be 
considered 
w/surgical backup 
Non-functional 
leads 
 1. Leads, due to 
design or failure, 
with potential threat 
if left in place (LOE: 
C) 
2. CIED implant 
would yield >4 leads 
on one 
side or >5 leads 
through SVC 
 (LOE: C) 
3. Need for MRI 
imaging w/o 
alternative (LOE: C) 
1. At time of 
indicated CIED 
procedure w/o 
contraindication to 
TLE (LOE: C) 
2. Need for MRI 
conditional CIED 
system (LOE: C) 
1. Redundant leads 
with <1 year life 
expectancy 
(LOE: C) 
2. Known 
anomalous lead 
placement (SCA, 
Ao, 
pleura, etc) or 
through a systemic 
atrium or 
ventricle* (LOE: C) 
3. *Can be 
considered 
w/surgical backup 
Chronic pain  Severe chronic pain 
at device or lead 
insertion site with 
significant 
discomfort not 
manageable 
by medical or 
surgical techniques 
and w/o 
acceptable alternative 
(LOE: C) 
 
  
Table 1. Indications for transvenous lead extraction 
Ao, aorta; CIED, cardiovascular implantable electronic device; DRE, device related endocarditis;  
LOE, level of evidence; SCA, subclavian artery; SCV, subclavian vein; SVC, superior vena cava;  
TE, thromboembolic; TLE, transvenous lead extraction; TV, transvenous; w/, with; w/o, without. 
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3.1. Pre-procedural and patient preparation  
Extractions can be performed either in the electrophysiology / catheterization laboratory on 
in the operating room. The site varies according to the preference and the availability of 
each center [29]. In any case, a cardiothoracic surgical back up should be always 
immediately available to intervene in case of life threatening complications. In the presence 
of such a team, safety is comparable in both settings [30]. In addition to the stand-by 
surgeon, the required personnel include the physician performing the procedure, a 
“scrubbed” and a “non-scrubbed” assistant, a third “outside the door” assistant to provide 
equipment and assist in an emergency, anesthesia support and an x-ray technician or other 
personnel to operate the fluoroscopy. Regarding the instrumentation, a full range of 
extraction tools should be available. Additional emergency equipment that should be 
present in the room or immediately available includes sets for pericardiocentesis, chest 
drainage, vascular repair, thoracotomy, sternotomy and cardio-pulmonary bypass. In 
addition, equipments for transthoracic and transesophageal echocardiography, temporary 
pacing and general anesthesia as well as vasopressors and other emergency medications 
should also be available [15].  
A detailed patient history should be obtained and a complete physical examination should 
be performed before the patient arrives to the interventional suite. Co-morbidites 
(anticoagulation therapy, renal impairment, allergies and antibiotic resistance) should be 
carefully taken into account when planning the procedure. Details about prior implantations 
and about the hardware in place are also mandatory. Technical characteristics of the lead 
should be known in advance. The vascular route has to be also explored in advance. Chest 
fluoroscopy can define the number, type and location of leads. Extravascular coursing can 
be detected through chest computed tomography [31]. Venography may be useful in case 
that a vascular access problem is anticipated. A transesophageal echocardiogram should be 
performed in all infected patients to check for vegetations. The size, shape and friability of 
vegetations may preclude transvenous extraction and support the decision to take the 
patient to the operating room. Although a clear cut-off point for the vegetation size has not 
been defined, many physicians would advocate surgical removal of leads of infected leads 
with large vegetations (>1-1,5 cm) [32],[33]. More recent evidence, however, suggests that 
even larger vegetations can be safely removed percutaneously [21]. Laboratory 
examinations should include: blood typing and crossmatch, a full blood count, coagulation 
profile, electrolytes, renal and liver function tests, virology screen (Hep B, C and HIV), C-
reactive protein and erythrocyte sedimentation rate. A pregnancy test for young females 
should not be omitted [15] Finally, the patient preparation concludes with the obtaining of 
written informed consent.  
The day of the procedure 4 packs of red blood cells should be immediately available. The 
patient is prepared with chlorexidine or povidone iodine and wrapped in a way to allow 
access ipsilaterally and contralaterally to the site of implantation, as well as to permit 
emergent pericardiocentesis, thoracentesis, thoracotomy, sternotomy or cardiopulmonary 
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bypass. Large bore iv. cannulae in peripheral veins are placed bilaterally to allow for rapid 
fluid infusion. A percutaneous arterial line is placed for direct blood pressure monitoring. 
Non-invasive automated blood pressure measurements, electrocardiographic monitoring 
and pulse oximetry are also available throughout the procedure. Femoral venous access is 
obtained for possible rapid fluid administration, for potential upgrade to a transfemoral 
approach or to facilitate the placement of a temporary pacing electrode. For patients who are 
pacemaker dependent, a temporary pacemaker lead inserted via the internal jugular or the 
femoral vein is adequate if the system is not infected and will be immediately replaced. In 
the case of infected leads several strategies of inserting a longer lasting temporary lead have 
been described (for example placing an active fixation permanent lead through the internal 
jugular vein) in order to permit for an adequate lead-free interval of antibiotic 
administration before the permanent system will be re-implanted. The externalized pulse 
generator after it has been cleaned and sterilized has been successfully used for temporary 
pacing in some centers [34]. In patients with ICDs tachycardia therapies should be switched 
off in order to prevent inappropriate shocks.  
3.2. Techniques and tools  
Generally speaking, leads can be removed with one of the following techniques: 
a. Manual traction without tools 
b. Traction mediated by some sort of weight or by application of a clamp to the stretched 
lead 
c. Mechanical sheaths, with or without the use of a locking stylet 
d. Laser-assisted lead extraction, with or without the use of a locking stylet 
e. Open chest extraction, with or without transvenous extraction tools 
f. Thransthoracic extraction using a paraternal, subxyphoid or intercostals approach [7]. 
If a decision has been made to proceed via the transvenous route after the device has been 
opened, the pulse generator is removed and the leads to the vascular entrance are freed 
through careful dissection usually with the aid of electroacautery. The incision is usually 
performed at the site of the initial one, although some physicians make a second incision 
over the venous entry site of the leads. Infected pockets should undergo thorough revision 
and microbial cultures of the tissue should be obtained. Irrigation with hydrogen peroxide 
or chlorexidine and meticulous removal of all infected tissue must follow. It is not clear if a 
complete capsulectomy needs to be done, although this is dictated by common sense in the 
case an ipsilateral implantation is planned. After the leads have been dissected all the way 
down to the venous entry site, the anchor sleeves are removed along with any suture 
remnants. It is essential that the leads be completely freed and remain intact. Damaged leads 
can be hard to extract. When using cautery it should be kept instead that polyurethane 
insulation is more heat sensitive than silicone [7]. Back bleeding issues may arise when 
dissecting at the venous entry site. A 2-0 suture placed as a snare in the surrounding tissues 
may help to solve this problem.  
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At this stage trasvenous extraction can be successfully performed in one of the following 
ways applied commonly in a steward fashion:  
Simple traction after the insertion of a regular stylet can be sufficient for recently implanted 
leads. Some experts advocate the gain of ipsilateral venous access through the 
introduction of a thin (i.e. 5 French) dilator and a guide wire prior to the traction attempt 
[3]. We do not routinely follow this practice. We simply place moderate traction on the 
free part of the lead trying to avoid stretching of the insulation or the induction of ectopy 
in the electrocardiogram. Unfortunately, there is not a priori certainty which lead will be 
successfully removed through this simple procedure. With traction, fibrous 
encapsulation often provides sufficient friction to prevent the force applied from being 
transmitted to the tip of the lead. When more force is needed, the tensile strength of the 
insulation or the conductor can be exceeded resulting in stretching or rupture. The lead 
may become irreversibly damaged complicating the extraction process and even leaving 
part of it indwelling in the venous circulation. Thus, it is of paramount importance for 
the lead to be removed in on piece. This can happen only if the operator has control of 
the body lead throughout the procedure binding the elements of the lead together. In 
that case, the exposed part of the lead can be used as a handle to remove its endovascular 
segments which will not be the case if the lead becomes distorted or elongated. Although 
it may be possible to snare fragments of the lead that have remained intravascularly after 
the main body of the lead has been removed, this may become increasingly hard at 
times.  
Regarding the type of the lead which can be extracted by simple traction, there is always a 
better chance for recently implanted and active fixation than passive fixation leads, 
especially if they are isodiametric and can be unscrewed before extraction. Sometimes this is 
not feasible because the mechanism is damaged or tissue is plugging the helix. In that case 
manual counterclockwise rotation of the lead body may unscrew the lead. However, to 
achieve this, the lead body must be free of adhesions in its entire course. In the case of atrial 
leads, where the helix has often extended through the thin atrial wall, failure to retract the 
helix makes traction particularly dangerous in removing a plug of atrial tissue with 
subsequent tamponade. As a rule, traction should not be placed on a lead not fully 
unscrewed unless a cardiac surgeon is present and the operating room is ready to accept the 
patient.  
In general, invagination of the myocardium may complicate any case of unopposed traction. 
Arrhythmias and hypotension can be the result of myocardial rupture, avulsion of a 
tricuspid valve leaflet or rupture of the superior vena cava or the subclavian veins. To avoid 
these complications, prolonged graded traction has been introduced. Historically speaking 
Bilgutay et al [35] created a graded weight and pulley system to deliver gentle traction on 
the externalized portion of the lead. This system required prolonged hospitalization with 
bed rest, increased the risk of infection and was proven frequently unsuccessful. This 
technique has been totally replaced nowadays from the use of locking stylets.  
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Traction via a locking stylet is directly applied at the tip, bypassing the conductor and the 
insulation. If manual traction is unsuccessful, the inner lumen is reamed with a conventional 
stylet to remove debris and the lead is cut approximately 5 cm from the vascular entry with 
a sharp scissor to maintain the shape of the spiral conductors. Care must be taken not to 
damage the distal lead, which should be firmly held by the assistant with his fingers or with 
a soft clamp if available. The central lumen of the lead is then identified and a locking stylet 
is inserted through it. To avoid pulling out the core and leaving the outer insulation in place, 
a ligature is used to tie down the insulation with the rest of the lead components and with 
the locking stylet. To choose the locking stylet of the appropriate size, the inner lumen 
diameter hat to initially be measured with the insertion of a series of gauze pins. A locking 
stylet of a size corresponding to the largest pin was chosen. This is not longer necessary 
since most of the contemporary stylets are designed to accommodate a wide range of 
conductor coil diameters. Locking stylets consist of a straight non-expandable wire that can 
be locked into the coil close to the tip of the lead. This specific design permits to focus the 
force of traction as close to the lead tip as possible. As a consequence, the risk of lead 
disruption is reduced and the likelihood of complete removal of the lead is increased 
[36],[37]. Several types of stylets with different locking exist. The most commonly used are: 
the Liberator (Cook Medical, Bloomington, Indiana, USA), the Lead Locking Device (LLD) 
EZ (Spectranetics, Colorado Springs, Colorado, USA) and the Extor Set (VascoMed, Binzen, 
Germany) (Figure 5).  
The locking mechanisms of the Liberator and the Extor Set are at the distal tip of the stylet 
providing focal traction at the tip of the lead, whereas the LLD EZ stylet grabs the lead in 
multiple areas and delivers stable traction along the entire lead length. An additional 
advantage of both the Extor and the LLD is that they provide the ability to unlock and 
reposition after initial deployment. This can facilitate the advancement of the locking stylet 
to the lead tip in cases the later is very tortuous or has sharp bends. In that case, the clinician 
can advance the stylet to the obstruction, lock the stylet, free the lead at that point, unlock 
the stylet and advance it to the next obstruction point, repeat the maneuver and manage to 
reach the lead tip at the end. The Bulldog Lead Extender (Cook Medical) is a tool that can be 
useful if a lead cannot receive a locking stylet due to extensive damage or a solid core 
design. It consists of a wire with a threadable handle through which the lead is passed and 
secured, thereby locking the insulation and conductor to the extender. This way the exposed 
part of the lead is securely grasped and extended to a workable length allowing a 
potentially more effective direct traction. 
There are still limitations to the use of a locking stylet. If the conductor is broken or 
distorted, e.g. with subclavian crush syndrome, it is not possible to introduce the stylet. It 
can also lack grip and dislocate during traction or too much force can damage the delicate 
locking mechanism. Further, as traction is still exerted via the distal conductor coil, this can 
unwind or disconnect from the electrode. As with direct traction, there is risk of 
invagination of the myocardium. 
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Figure 5. Various types of locking stylets. (A) The Liberator Locking Stylet (Cook Medical, 
Bloomington, Indiana, USA). (B) The Lead Locking Device (LLD) EZ (Spectranetics, Colorado Springs, 
Colorado, USA). In contrast to the Liberator locking stylet, the LLD locking stylet has a braided mesh 
over the entire length of a solid lead that expands when deployed. (C) The Extor Set (VascoMed, 
Binzen, Germany) (from Maytine et al. The challenges of transvenous lead extraction. Heart 2011;97:425-434, 
modified with permission) 
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Counter-pressure and Counter-traction: to overcome the limitations of a locking stylet, 
telescoping sheaths can be advanced over the lead with alternating counterclockwise and 
clockwise motions with moderate pressure. Fibrous bindings can be mechanically disrupted 
(counter-pressure). The outer sheath also functions as a guiding catheter facilitating the 
movement of inner sheath and alignment of the inner sheath and the lead. It is of paramount 
importance to use a locking stylet at the same time, as the leads are often too fragile to 
withstand the traction necessary to counter the forces applied to advance the sheath. Once 
the distal electrode is reached, the outer sheath can be positioned against the myocardium to 
prevent inversion (counter-traction). By pulling on the locking stylet, for several minutes if 
necessary, the tip of the lead is pulled inside the outer sheath. The force is thus concentrated 
at a small area of the scar tissue and the myocardium without gross displacement of the 
myocardium (Figure 6).  
 
Figure 6. Schematic representation of the forces of counterpressure, traction, and countertraction. (from 
Maytine et al. The challenges of transvenous lead extraction. Heart 2011;97:425-434, with permission) 
Telescopic sheaths are made of different materials (stainless steel, Teflon, and 
polypropylene) and are available in various sizes (7-16 French) (Figure 7). Sheath selection is 
determined by the clinical situation and the operator’s preference and experience. Teflon is 
soft and flexible but is unable to cut through dense scar tissue, while polypropylene is stiffer 
and better at disrupting encapsulating scar but must be used with caution so as to avoid 
vascular injury. Stainless steel sheaths are employed only to deal with dense and calcified 
fibrosis. If despite the use of a stainless steel sheath, tight adhesions prevent further 
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advancement to reach the tip, changing to a power sheath and/or upsizing to a larger sheath 
may solve the problem.  
 
 
 
Figure 7. Various types of telescopic sheaths (from Maytine et al. The challenges of transvenous lead 
extraction. Heart 2011;97:425-434, with permission) 
Even the removal of large vegetations (up to 4 cm) has been successfully attempted by very 
experienced operators with the use of 16 French sheaths [7]. Although counter-traction 
prevents invagination of the myocardium and diminishes the chance of rupture, perforation 
of the myocardium is still possible, especially in the thin-walled atrium.  
Powered sheath assisted extraction: If lead removal still proves unsuccessful, a powered sheath 
can be used as an alternative. Powered sheaths use a source of energy to make the dissection 
of encapsulating fibrous tissue easier and more efficient, thus enabling the advancement of 
the sheath along the lead with reduced countertraction and counterpressure forces. One 
such powered sheath is the Excimer Laser System (Spectranetics). It consists of optic fibers 
spirally warped between the inner and outer tubing of the sheath. At the tip of the device 
the fibers are arranged in a ring. Pulsed laser light is emitted from the fibers to ablate the 
tissue. The device is connected to a 308 nm XeCl excimer laser (Spectranetics CVX-300), 
which delivers pulsed light. As the penetration depth of 308 nm light in vascular tissue is 
~100 μ, it is completely absorbed in the tissue immediately in front of the tip. This results in 
an ablation depth, depending on the applied force, between 2 and 15 μ per pulse in the 
experimental setting. The influence of force is explained by increasing the mechanical effect 
of the micro-bubbles entrapped beneath the tip of the device in creating microscopic tears 
[38]. The sheath is advanced under fluoroscopic guidance over the lead body utilising the 
standard techniques of counterpressure and countertraction, and laser energy is delivered 
when encapsulating fibrous tissue halts sheath advancement. Tissue in direct contact with 
the sheath tip is ablated to a depth of 50 mm until the distal electrode is reached. It should 
be kept in mind that countertraction is still necessary to dislocate the lead tip. Great care 
must be paid to proper traction/countertraction techniques to prevent complications. Loss of 
coaxial orientation of the sheath and the lead can result in vascular injury. The leading edge 
of the bevel of the laser sheath should be oriented away from the vessel wall and the laser 
energy should be stopped before the lead tip is reached. Care must also be taken to avoid 
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damage of the tricuspid valve. The ablation results in a shearing of the fibrous bindings, 
often leaving a rim of scar tissue around the lead. Compared with mechanical telescoping 
sheaths, laser assisted extraction results in more frequent complete lead removal and 
shortened extraction times without an increase in procedural risk [39]. [40].  
The Perfecta Electrosurgical Dissection Sheath (Cook Medical) represents another type of 
powered sheath. The electrosurgical dissection sheath consists of an inner 
polytetrafluoroethylene (PTFE) sheath with bipolar tungsten electrodes exposed at the distal 
tip and an outer sheath for counterpressure and countertraction. Radiofrequency energy is 
delivered between the bipoles to dissect through fibrous binding sites, much like a surgical 
cautery tool, although the lead tip must be liberated with countertraction. In contrast to the 
Excimer Laser Sheath, the Electrosurgical Dissection Sheath permits a localised application 
of radiofrequency energy with linear rather than circumferential dissection of the 
encapsulating fibrous tissue. The focused and steerable dissection plane offers the potential 
advantages of improved precision.  
However, the sheath may have to be repositioned repeatedly as a result. The Electrosurgical 
Dissection Sheath offers a cost effective alternative to the Excimer Laser System without 
compromising safety or efficacy [41]. 
Finally, the Evolution and Evolution Shortie Mechanical Dilator Sheaths (Cook Medical) are 
‘hand powered’ mechanical sheaths that consist of a flexible, braided stainless steel sheath 
with a stainless steel spiral cut dissection tip. The sheath is attached to a trigger activation 
handle that rotates the sheath and allows the threaded metal end to bore through calcified 
and dense adhesions [42]. 
An inferior vena cava or transfemoral approach also named as “the inferior approach” has been 
developed as the alternative mode to be used often only after the approach via the implant 
vein (“superior approach”) has failed. It is also the procedure of choice for removal of 
broken or cut lead with free-floating ends. This technique is an old one [43] and over the 
years the following tools have been developed to assist in the extraction of leads by the 
femoral vein: 
1. The Byrd Femoral Work Station (Cook Vascular Inc, Leechburg, PA) 
2. The Dotter retriever Snare 
3. The Curry Loop Snare 
4. The Amplatz Snares 25 mm, 25 mm (Microvena Corp) 
5. The Needls Eye Snares (Cook Vascular Corp) [44] (Figure 8) 
Virtually all the femoral extraction techniques use some form of snaring. Two 
fundamental techniques have evolved. The first uses the combination of a wire loop and 
catheter to snare free ends or free-floating leads. The other creates a loop around the lead 
to be removed when there is no free end available for simple snaring. In any case, a long 
sheath is introduced via the femoral vein and positioned close to the lead. Then, a 
retriever is inserted through the sheath to grab and secure the lead close to the tip. The 
isodiametric proximal part of the lead (with the connector cut off) is pulled down through 
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the fibrous scar tissue. The outer sheath is then advanced over the doubled up lead to 
disrupt the scar tissue, while the lead is kept under tension by the retriever. When the 
sheath reaches the tip, counter-traction is applied. In comparison with the superior 
approach, only a short distance of scar tissue needs to be disrupted as the proximal 
isodiametric part of the lead can be simply pulled down. Therefore, even if no locking 
stylet has been used to reinforce the lead, the shorter distance to cover decreases the 
chance of elongating the lead. “Reversibility” is one of the most important principles to be 
followed with snaring techniques since the process of grasping a lead must be totally 
reversed and the lead freed again if necessary. If this situation cannot be reversed 
thoracotomy remains the only solution.  
 
Figure 8. The Needle’s Eye snaring tool 
Beyond that, the main challenge of femoral retrieval remains manipulating the tools and 
snaring the lead in three dimensions under the guidance of two dimensional fluoroscopic 
imaging. The recent description of a novel technology to facilitate extraction and the 
maintenance of vascular access proposed a hybrid superior and inferior approach, with 
femoral snaring of the lead to stabilise the lead while countertraction and counterpressure 
are used through the right jugular vein to free the lead, reiterating the clinical importance of 
femoral retrieval [45],[46]. 
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4. Complications 
The major risks of transvenous lead extraction include: cardiac perforation (1-4%), 
emergency cardiac surgery (1-2%) and death (0.4-0.8%).34 (Table 2). However, the risk of an 
individual varies according to the presence or absence of the following factors: 
 Age of the patient (risk increase with advanced age) 
 Gender of the patient (risk higher in female patients) 
 Comorbidities 
 Presence of calcifications on the leads 
 Presence and size of vegetations 
 Duration of implant 
 Physical characteristics of the lead (fragility, condition) 
 Presence of multiple leads 
 Presence of ICD leads, especially with a superior vena cava coil 
 
Major complications Minor complications 
Death Pericardial effusion not requiring 
intervention 
Cardiac avulsion requiring intervention 
(percutaneous or surgical) 
Haemothorax not requiring intervention 
Vascular injury requiring intervention 
(percutaneous or surgical) 
Pocket haematoma requiring reoperation 
Pulmonary embolism requiring surgical 
intervention 
Upper extremity thrombosis resulting in 
medical treatment 
Respiratory arrest/anesthesia related 
complication prolonging hospitalization 
Vascular repair near implant site or venous 
entry site 
Stroke Hemodynamically significant air embolism 
Cardiovascular implantable electronic 
device infection at previously non-infected 
site 
Migrated lead fragment without sequelae 
 Blood transfusion as a result of 
intraoperative blood loss 
 Pneumothorax requiring a chest tube 
 Pulmonary embolism not requiring 
surgical intervention 
Table 2. Potential complications of transvenous lead extraction. 
Complications result primarily from forces applied to separate leads from fibrous 
connections within the large vessels and the heart. Disruption of the superior vena cava or 
brachiocephalic vein is the most devastating complication of lead extraction, as it results 
in swift exsanguination in the thoracic cavity and is very difficult for the surgeon to 
control or repair. The superior vena cava has a wall thickness of sometimes <1 mm and is 
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vulnerable for damage by the sheaths. Of note, the pathway of least resistance is the 
vessel wall rather than the scar. Of course, damage to the superior vena cava and its 
branches veins may be minimized with a femoral approach. Some have suggested the use 
of a large balloon to tamponade bleed from the superior vena cava until the surgeon 
arrives. Death can occur or emergency surgery may be needed due the above 
complication but also due to cardiac tamponade from cardiac rupture or due pulmonary 
embolism from the dislodgment of large lead vegetations. Infection with re-implantation 
is another potential problem to consider. Proper care of the infected pocket is essential to 
prevent recurrent infection. Some operators elect to leave the wound open to heal by 
secondary intention while others prefer tight suturing of tissues to eliminate any residual 
cavity. As a rule, a new device should never be placed in a previous infected pocket. 
However, the most important principle in preventing lead extraction complications is to 
avoid lead extraction by meticulous operative technique at the time of the initial 
implantation and by early recognition of potential problems in the immediate post-
operative period [47]. 
5. Lead extraction success rate 
The Expert Consensus of the Hearth Rhythm Society has defined the success of the lead 
extraction procedure in two different ways [6]: Complete Procedural Success has been 
considered the removal of all targeted leads and all lead material from the vascular 
space, with the absence of any permanently disabling complication or procedure related 
death. On the other hand as Clinical Success has been defined the removal of all 
targeted leads and lead material from the vascular space, or retention of a small portion 
of the lead that does not negatively impact the outcome goals of the procedure. This may 
be the tip of the lead or a small part of the lead (conductor coil, insulation, or the latter 
two combined) when the residual part does not increase the risk of perforation, embolic 
events, perpetuation of infection or cause any undesired outcome. Finally, the 
Committee defined as Failure the inability to achieve either complete procedural or 
clinical success, or the development of any permanently disabling complication or 
procedure related death.  
Results of transvenous extraction have been repeatedly reported as associated with a high 
success rate of complete (>90%) or partial (>95%) removal with a concomitant low rate of 
complications in experienced centers [48],[49],[50]. The use of extraction sheaths ranged 
from 60-80% in these studies. Nevertheless, the success rate of manual only traction alone or 
with the use of locking stylets is not negligible ranging form 15-30% in recent studies. More 
recently, de Bie et al [51] reported a substantially higher clinical success rate of ~85% in >250 
removal procedures with the use of manual traction without the assistance of extraction 
sheaths. This finding was particularly true for leads implanted > 2.6 years. Since it is not 
clearly defined when an attempt should be considered unsuccessful, the efficacy of these 
simpler techniques seem to be largely dependent of the availability of the more complex 
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ones (i.e. telescopic or laser sheaths). That means that if an operator has a wide range of 
tools available, he will give up more easily on a resistant to traction lead, moving to more 
sophisticated techniques and strategies [51].  
6. Removal of left ventricular pacing leads 
Nowadays CRT is considered a standard therapy used to improve symptoms and prognosis 
in heart failure. Increasing evidence confirming the benefits of CRT has led to widespread 
implantation of CRT devices with technically challenging procedures, followed by frequent 
dislodgement of the coronary sinus (CS) lead or infections and requirement for extraction 
and re-implantation of the device. During the last decade, evolutionary changes have 
emerged in CS lead technology and techniques to optimize CRT function during 
implantation and permit the removal of left ventricular (LV) pacing leads with minor 
complications.  
Coronary sinus lead implantation is a complex procedure with several limitations and 
hazards. According to several studies, the procedure is usually time consuming with long 
fluoroscopy times and the implantation success rate is reduced compared to conventional 
procedures (estimated between 90% to 97%) [52-56]. With the introduction of special 
delivery sheaths and the so-called ‘over the wire technology’ the breakthrough of LV pacing 
became reality in the early 2000s, yet lead stability remains problematic mainly due to 
different coronary sinus anatomies [57-58]. Because no muscular trabeculae is found in the 
CS for anchoring of the lead, the tip has to be pushed as distal as possible in a wedge 
position in a lateral or a postero-lateral CS branch and is typically non-actively fixated. Such 
an ideal position of the LV lead cannot be reached in several cases owing to small and 
tortuous venous anatomy, phrenic nerve stimulation or sub-optimal hemodynamics due to 
close proximity to the right ventricular lead. As a result, detectable CS lead dislodgement 
has been observed in about 4-8.6% of patients during follow-up, accompanied by loss of 
capture and need for repositioning [52,59,60]. To overcome these limitations, pre-shaped 
leads (curved in one or more dimensions) have been developed to offer stability even in 
proximal positions and in larger veins. Coronary sinus side branch stenting has also been 
performed in several occasions [61-62]. Finally, the development of an active fixation CS 
lead (Attain StarFix 4195, Medtronic) has also been achieved [63]. This lead body has a 55D 
polyurethane coating that expands into pleated loops near the electrode tip to increase its 
diameter and promote fixation (practically reaching stability of 100%), along with a small 
amount of steroid at the electrode tip to reduce inflammation in the surrounding tissue [64] 
(Figure 9). 
In parallel to the rapid growing experience with the implantation of CS leads, a new and 
interesting field relating to LV pacing lead extraction and subsequent re-implantation has 
been developed. It should be noted, however, that in comparison to the extensive data 
available on conventional pacing and ICD lead extraction, the experience with LV leads is 
still limited. Similarly to conventional devices, infection seems to be the primary 
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indication for removal in the case of CRT devices too. On the other hand, it might be 
expected that removing leads from fragile and tortuous CS vein tributaries, especially 
with the use of larger-bore sheaths (mechanical or laser) which may not fit into the distal 
branches, would lend itself to a higher risk of complications. Indeed, the high rate of 
hemopericardium and dense scar tissue in-growth or vein occlusion in animal models 
[65,66] were early findings suggesting the need for extreme care in the removal of CS 
leads and for detailed preoperative knowledge of the CS anatomy. Nevertheless, 
published data so far suggest that CS leads can be safely and successfully removed 
percutaneously and that CS lead extraction is not more hazardous than conventional 
PM/ICD lead extraction (Table 3), although post-extraction complete occlusion of the 
branch vein previously implanted with an LV lead followed by re-implantation 
complications may become a particular problem occasionally [67]. It appears that CS leads 
implanted for <2 years are amenable to manual traction [68] and even extraction of active 
fixation CS leads has been reported due to prolonged manual traction alone or careful use 
of a laser sheath within the CS. [69],[70],[71].  
 
Figure 9. Medtronic Attain StarFix 4195 Coronary Sinus Lead at four stages of deployement. 
All the previously mentioned techniques have been successfully used for the removal of 
CS infected or malfunctioning leads. Tyers et al [72] reported a series of 14 left ventricular 
lead extractions, all successfully removed with the use of locking stylets and powered 
sheaths. Bongiorni et al [73] have reported one of the earlier and larger single centre 
experiences on extraction of LV pacing leads: manual traction using a standard stylet only 
was effective in the majority of cases (73%) and mechanical dilation with polypropylene 
sheaths was necessary (27%) when tight adherence was found along the catheter course. 
 
Current Issues and Recent Advances in Pacemaker Therapy 210 
In particular, adherence in CS lead extraction was located more commonly in the systemic 
veins (subclavian vein 60%, innominate vein 30%, superior vena cava 20%, right atrium 
20%) rather than inside the CS (10%). When areas of adherence were found inside the CS 
(never in its branches), dissection through a transfemoral approach was chosen and no 
major complications were seen. Safety and efficacy of transvenous CS lead removal was 
also confirmed by Di Cori et al [74] in a large, single-center experience involving 
extraction of 147 CS pacing leads. Nearly one-third of procedures were resistant to 
manual traction and thus required mechanical dilation or transfemoral approach. 
Complications were rare, there was no predictable pattern among manual traction or 
mechanical dilation removal techniques and fibrous adherence sites were also found 
mainly in non-CS locations (subclavian vein 66%, innominate vein 48%, superior vena 
cava 32%, right atrium 20% and CS 14%). Most recently, Williams et al [75] confirmed 
their high procedural success of 10-year experience regarding percutaneous removal of CS 
leads. Among 71 patients they explanted 60 CS leads and 143 non-CS leads: CS extraction 
had 0% operative mortality - 2.8% postprocedural mortality (in hospital <30 days) - minor 
complication rates 5.6% and major complication rates 1.4%. The majority of CS leads were 
extracted using manual traction and laser sheath dissection was required in 10% (laser 
was used within the CS only in two cases). 
In conclusion, extensive data are available on conventional pacing and ICD lead 
extraction but only limited experience with LV leads exists. The LV pacing leads may be 
removed easily by manual traction in a large number of cases, but coronary sinus (CS) 
adherences may complicate extraction requiring mechanical dilation or ablative 
extraction techniques. In addition to CS remnant adherences, post-extraction venous 
occlusion might complicate the eventual re-implantation. Nevertheless, CS lead 
extraction seems to be not more hazardous than conventional pacemaker and 
defibrillator lead extraction. The evolving use of CRT in current clinical practice, is 
expected to improve the techniques and provide us with more data regarding the 
feasibility and safety of LV lead removal.  
Author 
CS leads 
extracted infection sepsis malfunction 
time from 
implant 
(months) 
manual 
traction
mechanical 
dilation 
major 
compli-
cations 
success 
rate 
Bongiorni  
et al73 37 43.3% 29.7% 27% 19.5 ± 16.5 73% 27% 0% 100% 
Williams  
et al75 60 31% 31% 38% 35.8 90% 10% (laser) 1.4% 98% 
Di Cori et al74 147 56% 24% 20% 29±25 70% 30% 0.7% 99% 
De Martino  
et al77 12 58%  42% 13.9±11.7 100%  0% 100% 
Hamid et al68 32 56.2  43.8% 26.5±28.7 87.5% 
12.5% 
(laser) 0% 100% 
Tyers et al72 14    not available   7% 100% 
Kasravi et al76 14    17.4±12.2   0% 100% 
Table 3. Coronary sinus lead extraction: differences and similarities between reports 
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